HOUSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV, “the Company”), announced today that the Company intends to voluntarily terminate the listing of its common stock on the Nasdaq Global Select Market (“Nasdaq”) and, based upon ownership of its shares by fewer than 300 holders of record, deregister its common stock under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and suspend its public reporting obligations.
- Actor and USO Global Ambassador Wilmer Valderrama to Be Recognized at USO Gala - May 22, 2025
- UPDATE – Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - May 22, 2025
- Superior Group of Companies to Participate in the Barrington Research Spring Investment Conference - May 22, 2025